Abstract:During the period of 1958-1986, a series of 125 patients with pathologically proven hepatocellular carcinoma (HCC) surviving more than 5 years was collected in authors' institute. Thirty seven of them survived more than 10 years, the longest being 30 years. Of the entire series, 55.2% of patients was discovered by screening, 48.0% of patients was subclinical HCC, 80.0% of patients had solitary tumor, and 53.6% of patients had tumor size smaller than 5 cm. Pathological findings revealed that 90.2% of tumor was grade I and II (Edmondson grading) and 81.6% of patients associated with cirrhosis. The serum HBsAg was positive in 63% and anti-HBc in 80% of the patients who had checked the HBV markers. Of the 125 patients, 108 patients received resection, 67 patients were small HCC resection, 41 patients were non-small HCC resection, re-resection for subclinical recurrence or solitary lung metastasis was done in 26 patients with resection. Limited resection amounted to 54.6% of patients with resection. Of the 125 patients, 17 patients received palliative surgery other than resection, including hepatic artery ligation, cannulation, or their combination, etc. Eight out of the 17 patients received second stage resection due to marked shrinkage of tumor. It is concluded that early resection remained the major approach to get a long-term survivor, re-resection for subclinical recurrence is also of proved merit. Resection of huge tumor is still useful but less effective. Cyto-reduction and sequential resection is a new trend. Primary liver cancer (PLC) has long been recognized as incurable malignancy with extremely low 5-year survival rate. According to the cancer statistics in the United States, the relative 5-year survival rates for patients with PLC was 2% in 1960-1963, 3% in 1970-1973, 4% in 1974-1976, 3% in 1977-1980 and 5% in 1981-1986. Patients with PLC survived more than 5 years were rarely reported in the literature. In 1971, Curutchet collected worldwide data from 45 authors covering the period for 65 years (1905-1970), only 45 patients with PLC were found to be 5-year survivors. Thanks to the progress in tumor markers, particularly alpha fetoprotin (AFP) and new localization measurements, diagnosis and treatment are possible in subclinical stage. Based on combined strategies to the treatment of PLC including resection of small liver cancer, re-resection of subclinical recurrence after curative resection, multimodality treatment, and sequential resection after shrinkage of tumor, the 5-year survival of PLC has gradually increased.(ABSTRACT TRUNCATED AT 400 WORDS)

Five‐year survival post hepatectomy for colorectal liver metastases in a real‐world Chinese cohort: Recurrence patterns and prediction for potential cure

Long-term postoperative survival prediction in patients with colorectal liver metastasis.

Survival and Prognostic Factors of Colorectal Liver Metastases after Surgical and Nonsurgical Treatment.

Outcome of Patients with Colorectal Liver Metastasis: Analysis of 1613 Consecutive Cases

Outcome of Patients with Colorectal Liver Metastasis: Analysis of 1,613 Consecutive Cases.

Predictors and outcomes of recurrence after resection of colorectal liver metastases]

Predictors of early recurrence and long-term survival in patients after resection for colorectal cancer liver metastases with a low-risk on clinical risk score

Analysis of One Hundred and Twenty Five Patients with Primary Liver Cancer Surviving More Than Five Years.

Recurrent colorectal liver metastasis patients could benefit from repeat hepatic resection

[Risk Factor Analysis of Early Recurrence after Resection of Colorectal Liver Metastasis].

Prognostic Factors Of Primary Liver-Cancer - Report Of 83 Patients Surviving 5 Years Or More Compared With 811 Patients Surviving Less Than 5 Years

Long-term survival and recurrence after curative resection for hepatocellular carcinoma in patients with chronic hepatitis C virus infection: a multicenter observational study from China

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

Liver resection for colorectal metastases: results and prognostic factors with 10-year follow-up

Survival Investigation in Patients with Colorectal Liver Metastasis: A Single-Institution Analysis.

Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study

Recurrent Colorectal Liver Metastasis Patients Would Benefit to Repeat Hepatic Resection

An Approach Improving Long-Term Outcome of Surgery for Hepatocellular Carcinoma: Analysis of 113 Patients Surviving More Than Five Years

Patterns of Recurrence after Curative Intent Hepatic Resection for Colorectal Liver Metastasis

Long-term survival and cure model following liver resection for breast cancer metastases

Long-term Survivors after Resection for Primary Liver Cancer. Clinical Analysis of 19 Patients Surviving More Than Ten Years